TABLE 4.
Milan category |
Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
I | II | III | IVa | IVb | V | VI | ||||
No adequacy (n = 119) | Malignant | 1 | 2 | 2 | 2 | 1 | 2 | 15 | 25 | |
Benign | 7 | 2 | 0 | 4 | 3 | 0 | 0 | 16 | ||
No follow-up | 29 | 13 | 4 | 15 | 10 | 0 | 7 | 78 | ||
Total | 31.1% (37/119) | 14.3% (17/119) | 5.0% (6/119) | 17.6% (21/119) | 11.8% (14/119) | 1.9% (2/119) | 18.5% (22/119) | 119 | ||
Adequacy performed (n = 431) | Malignant | 1 | 1 | 4 | 0 | 13 | 7 | 56 | 82 | |
Benign | 3 | 3 | 5 | 33 | 19 | 0 | 0 | 63 | ||
No follow-up | 46 | 76 | 18 | 83 | 37 | 6 | 20 | 286 | ||
Total | 11.6% (50/431) | 18.6% (80/431) | 6.3% (27/431) | 26.9% (116/431) | 16.0% (69/431) | 3.0% (13/431) | 17.6% (76/431) | 431 | ||
Grand Total | 15.8% (87/550) | 17.6% (97/550) | 6.0% (33/55) | 25.1% (137/550) | 15.1% (83/550) | 2.7% (15/550) | 17.8% (98/550) | 550 |